PinnyPeptide

Hexarelin vs Ipamorelin

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Hexarelin

Growth Hormone

The most potent GHRP — strong GH release with documented cardioprotective signaling.

Peptide B

Ipamorelin

Growth Hormone

Selective growth hormone secretagogue with minimal side effects.

Typical vial

5 mg

Typical dose

100 mcg

Half-life

~55 minutes

FDA status

Not FDA approved for any indication.

Typical vial

5 mg

Typical dose

100-300 mcg

Half-life

~2 hours

FDA status

Not FDA approved for human use. Clinical development discont…

Hexarelin effects

  • Most potent acute GH release of any GHRP at equivalent doses
  • Documented cardioprotective signaling via CD36 receptor
  • Stimulates IGF-1 elevation over multi-week courses
  • Supports tissue repair and recovery
  • Mild secondary stimulation of ACTH and prolactin

Ipamorelin effects

  • Selectively stimulates growth hormone release
  • Promotes fat metabolism without affecting cortisol
  • Supports lean muscle growth and recovery
  • Improves sleep quality through enhanced GH pulsatility
  • Does not significantly increase appetite or prolactin

Hexarelin side effects

  • Strongest cortisol and prolactin elevation of the GHRPs
  • Pronounced water retention
  • Lethargy and fatigue with chronic use
  • Rapid tachyphylaxis (response diminishes after 3-4 weeks)
  • Mild appetite stimulation

Ipamorelin side effects

  • Mild head rush or flushing immediately after injection
  • Transient water retention
  • Injection site irritation
  • Occasional lightheadedness

Hexarelin dosing ranges

Short-course GH stimulation

100 mcg · Two to three times daily (SubQ) · 4 weeks maximum, then 4-week break

Combined with CJC-1295 (Mod GRF)

100 mcg of each · Two to three times daily · 4 weeks on / 4 weeks off

Cardioprotective research

1-2 mcg/kg · Per protocol (research-only) · Variable

Ipamorelin dosing ranges

GH optimization and anti-aging

100-300 mcg · Two to three times daily (SubQ) · 8-12 weeks

Combined with CJC-1295 (Mod GRF)

100-200 mcg · Two to three times daily · 8-12 weeks

Hexarelin vs Ipamorelin — common questions

What is the difference between Hexarelin and Ipamorelin?

Hexarelin: The most potent GHRP — strong GH release with documented cardioprotective signaling. Typical dose 100 mcg. Ipamorelin: Selective growth hormone secretagogue with minimal side effects. Typical dose 100-300 mcg. Both fall under the Growth Hormone category.

Can you stack Hexarelin and Ipamorelin?

Stacking Hexarelin with Ipamorelin is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Hexarelin or Ipamorelin?

Hexarelin is typically dosed: Two to three times daily (SubQ) for Short-course GH stimulation; Two to three times daily for Combined with CJC-1295 (Mod GRF); Per protocol (research-only) for Cardioprotective research. Ipamorelin is typically dosed: Two to three times daily (SubQ) for GH optimization and anti-aging; Two to three times daily for Combined with CJC-1295 (Mod GRF).

Are Hexarelin and Ipamorelin FDA approved?

Hexarelin: Not FDA approved for any indication. Ipamorelin: Not FDA approved for human use. Clinical development discontinued by Novo Nordisk.

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free